Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. (HOWL) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 142 transactions totaling $96.9M, demonstrating a bullish sentiment with $85.5M in net insider flow. The most recent transaction on Jan 15, 2026 involved a sale of 37,413 shares valued at $20.6K.
HOWL Insider Activity Summary
Who Is Buying HOWL Stock?
No significant insider buying has been recorded for HOWL in the recent period.
Who Is Selling HOWL Stock?
No significant insider selling has been recorded for HOWL in the recent period.
Is Werewolf Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HOWL is bullish with an Insider Alignment Score of 94/100 and a net flow of $85.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
HOWL Frequently Asked Questions
Understanding HOWL Insider Activity
Insider trading at Werewolf Therapeutics, Inc. (HOWL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading HOWL stock, having executed 142 transactions in the past 90 days. The most active insider is Rajeev M. Shah (Executive), who has made 5 transactions totaling $31.5M.
Related Tools
Track Werewolf Therapeutics, Inc. Insider Activity
Get notified when executives and directors at HOWL file new Form 4 transactions